1M6MYTD1A5AMAX
Cargando cotizaciones...
Previsión
| Comprar |
1 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
Supply stoppages weigh on Olympus: 2026 sales forecast cut 2% on a constant-currency basis
For Q3 of fiscal 2026 Olympus reported sales of 2,610 Oku Yen (+4% on a constant-currency basis) and adjusted operating profit of 393 Oku Yen (margin 15.1%). Due to supply stoppages of about 90 Oku Yen caused by FDA inspections, the company lowered its sales forecast excluding currency effects by 2% but kept its operating margin targets unchanged (now 12.7–13.9%). CEO Bob White announced measures to remedy the supply issues, strengthen quality and regulatory teams, and implement strategic initiatives to improve margins and growth; the stock fell 5.22% after the announcement. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | jun 2026 | |
|---|---|---|
| Ingresos | 1,31B | 7,94% |
| Beneficio bruto | 856,00M | 7,62% |
| Beneficio neto | 104,26M | 97,01% |
| EBITDA | 268,02M | 56,17% |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 12,16B€ |
Número de acciones | 1,06B |
Máximo/mínimo de 52 semanas | 11,79€ - 6,94€ |
| Dividendos | No |
Beta | 0,21 |
Ratio P/E | 30,88 |
Ratio PEG | −1,11 |
Ratio P/B | 3,16 |
Ratio P/S | 2,32 |
Perfil de la empresa
| Nombre | OLYMPUS CORP. ADR |
| CEO | Robert White |
| Empleados | 28.138 |
Descubrir activos
Los accionistas de OLYMPUS CORP. ADR también invierten en los siguientes activos
